Global  Diabetes Conference and Expo

June 11th-12th, 2018

Dubai, UAE

Theme: Innovative Ideas and Approaches for Striving the Future of Diabetes.

 

About GSC

The GSC invites all the participants across the globe to attend the Global Diabetes Conference and expo, which will be held in June 11th-12th, 2018 Dubai UAE. which will provide an international platform for discussion of present and future challenging and emerging issues in Diabetes. Diabetes 2018 will also provide the excellent opportunity to meet Physicians, Researchers, Clinicians, Experts, Directors, Professors, Associate Professors, Dietitians, Certified diabetes educators, other health care professionals and who manage diabetes related complications.

Nursing Speakers


The Global Scientific Conferences invites all the participants across the globe to attend the Global Diabetes Conference and expo, which will be held in June 11th-12th, 2018 Dubai UAE. which will provide an international platform for discussion of present and future challenging and emerging issues in Diabetes. Diabetes 2018 will also provide the excellent opportunity to meet Physicians, Researchers, Clinicians, Experts, Directors, Professors, Associate Professors, Dietitians, Certified diabetes educators, other health care professionals and who manage diabetes related complications

The main theme of Diabetes 2018 conference is : Innovative Ideas and Approaches for Striving the Future of Diabetes.

Global Conference on Diabetes 2018 is anticipating around 300 participants around the globe and the two day conference will provoke Plenary sessions, Keynote speeches, Poster, and Oral presentations.

The GSC invites all the participants across the globe to attend the Global Diabetes Conference and expo, which will be held in June 11th-12th, 2018 Dubai UAE. which will provide an international platform for discussion of present and future challenging and emerging issues in Diabetes. Diabetes 2018 will also provide the excellent opportunity to meet Physicians, Researchers, Clinicians, Experts, Directors, Professors, Associate Professors, Dietitians, Certified diabetes educators, other health care professionals and who manage diabetes related complications.

Market Analysis

  • Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. According to WHO Diabetes was estimated to affect 371 million people till the end of 2011in US. Whereas, new figures indicate that the number of people living with diabetes is expected to rise from 371 million in 2012 to 552 million by 2030. This indicates an urgent alarm for its management.
  • “Regionally, we saw the largest increase in diagnosed diabetes prevalence in the South, followed by the West, Midwest, and Northeast,” with CDC’s Division of Diabetes Translation and lead author of the report. “These data also reinforce findings from previous studies, which indicate that the prevalence of diagnosed diabetes is highest in the southern and Appalachian states.”

As the number of patients grows across the globe, there has never been a stronger and more urgent need for therapeutic measures that arrest the growth of the disease and alleviate its secondary manifestations. In Type 1 diabetes total beta-cell loss occurs. In Type 2 diabetes, partial beta-cell loss occurs before diagnosis, and the progressive beta-cell loss during the life of the patient increases the severity of the disease. This addresses novel therapies for these deficiencies in clinical and preclinical evaluation.

Many International Conferences and Diabetic therapies meetings/ symposium and workshops have been organized on different topics related to the risk factors related to diabetes across the globe such as glucose tolerability conference, diabetes stem cell cure conference, anti-diabetic agents meetings, obesity conferences, weight loss conferences, Islet transplantation international conference, glucose variability conferences etc. Besides that many international events such as diabetes alternative medicines events, insulin pump therapy events, pancreatic dysfunction events, recombinant approaches for diabetes events etc. Targeted Therapy Events have been also taking place in order to find a weapon against fatal diseases like diabetic foot, insulin resistance, glucose tolerability, obesity and to discuss the role of diabetes in cardiovascular diseases, kidney diseases, risk of cancer and intolerability to cure the wound which will gives a better insight about the associated causes and disease portfolio.

Why in Dubai

The UAE has the second-highest diabetes rate in the world, with an estimated 20percent of residents and 25percent of nationals suffering from the disease. Nearly three-quarters of diabetes patients in the UAE do not have their diabetes under control, a challenge particularly pronounced among children and young adults. It is estimated that 40 to 50percent of diabetics in the UAE are unaware they even have the disease. Left unchecked, the spread of diabetes portends devastating social and fiscal consequences, including threats to economic progress and investment stability in the region.

The United Arab Emirates (UAE) has achieved an impressive level of economic development. In particular, its healthcare sector is among the best performing in the world. By many measures of health status (infant mortality, life expectancy, eradication of numerous infectious diseases), the UAE has reached levels comparable with other developed nations. In addition, the health infrastructure which includes facilities, equipment, and staff, are of high quality. This healthcare is offered freely or at low-cost to citizens and highly subsidised to residents and tourists. The fact that the UAE has made such great strides in achieving a high level of excellence in accommodating the healthcare needs of so many people is a testament to wise resource management policies. However, at least one health pandemic threatens to unravel the system’s stability: diabetes. The World Health Organization (WHO) and the International Diabetes Federation (IDF) call diabetes the 21st century’s leading healthcare challenge. Diabetes complications and mortality create social and economic challenges that affect individuals, families, businesses, and society as a whole. Six Middle East North Africa (MENA) region countries – Bahrain, Egypt, Kuwait, Oman, Saudi Arabia, and the United Arab Emirates (UAE) – are among the world’s 10 highest for prevalence of diabetes and impaired glucose tolerance. By 2020, 32percent of the adult UAE population (age 20-79) may have diabetes or pre-diabetes, while other data indicate that the adult UAE population (ages 18 and above) has already reached a diabetes or pre-diabetes rate of 44percent. If trends continue, the IDF projects that by 2030, the number of people with diabetes in the Middle East North Africa (MENA) region will almost double, reaching 59.7 million.

Diabetes Associations

Major Diabetes Associations around the Globe

  • Diabetes Indian Association
  • Canadian Diabetes Association
  • International Diabetes Federation
  • Diabetes Australia
  • Austrian Diabetes Association
  • Diabetes UK
  • Diabetes South Africa
  • Spanish Diabetes Society (Spain)
  • Swedish Diabetes Association
  • Korean Diabetes Association

Major Diabetes Associations in Dubai

  • Emirates diabetes society
  • Global Health Partner Diabetes Centre Dubai
  • Cleveland Clinic Dubai
  • Joslin Diabetes Centre Dubai
  • Al Jalila Foundation Research Centre in Dubai
  • Diabetes Research Institute Dubai
  • Diabetes Education in Tribal Schools (DETS)
  • Imperial College London Diabetes Centre Dubai